Randomized summer camp crossover trial in 5-to 9-year-old children: Outpatient wearable artificial pancreas is feasible and safe

82Citations
Citations of this article
132Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Objective The Pediatric Artificial Pancreas (PedArPan) project tested a children-specific version of the modular model predictive control (MMPC) algorithm in 5-to 9-yearold children during a camp. RESEARCH DESIGN AND METHODS A total of 30 children, 5-to 9-years old, with type 1 diabetes completed an outpatient, open-label, randomized, crossover trial. Three days with an artificial pancreas (AP) were compared with three days of parent-managed sensoraugmented pump (SAP). RESULTS Overnight time-in-hypoglycemia was reduced with the AP versus SAP, median (25th-75thpercentiles): 0.0% (0.0-2.2) vs. 2.2% (0.0-12.3) (P 5 0.002), without a significant change of time-in-target, mean: 56.0% (SD 22.5) vs. 59.7% (21.2) (P < 0.430), but with increased mean glucose 173 mg/dL (36) vs. 150 mg/dL (39) (P < 0.002). Overall, the AP granted a threefold reduction of time-in-hypoglycemia (P < 0.001) at the cost of decreased time-in-target, 56.8% (13.5) vs. 63.1% (11.0) (P < 0.022) and increased mean glucose 169 mg/dL (23) vs. 147 mg/dL (23) (P < 0.001). CONCLUSIONS This trial, the first outpatient single-hormone AP trial in a population of this age, shows feasibility and safety of MMPC in young children. Algorithm retuning will be performed to improve efficacy.

References Powered by Scopus

Home use of an artificial beta cell in type 1 diabetes

400Citations
N/AReaders
Get full text

Fully integrated artificial pancreas in type 1 diabetes: Modular closed-loop glucose control maintains near normoglycemia

274Citations
N/AReaders
Get full text

2 month evening and night closed-loop glucose control in patients with type 1 diabetes under free-living conditions: A randomised crossover trial

190Citations
N/AReaders
Get full text

Cited by Powered by Scopus

Effect of artificial pancreas systems on glycaemic control in patients with type 1 diabetes: a systematic review and meta-analysis of outpatient randomised controlled trials

377Citations
N/AReaders
Get full text

Artificial pancreas treatment for outpatients with type 1 diabetes: Systematic review and meta-Analysis

341Citations
N/AReaders
Get full text

Home use of a bihormonal bionic pancreas versus insulin pump therapy in adults with type 1 diabetes: a multicentre randomised crossover trial

202Citations
N/AReaders
Get full text

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Cite

CITATION STYLE

APA

Del Favero, S., Boscari, F., Messori, M., Rabbone, I., Bonfanti, R., Sabbion, A., … Bruttomesso, D. (2016). Randomized summer camp crossover trial in 5-to 9-year-old children: Outpatient wearable artificial pancreas is feasible and safe. Diabetes Care, 39(7), 1180–1185. https://doi.org/10.2337/dc15-2815

Readers over time

‘16‘17‘18‘19‘20‘21‘22‘23‘24‘2507142128

Readers' Seniority

Tooltip

PhD / Post grad / Masters / Doc 38

49%

Researcher 23

30%

Professor / Associate Prof. 13

17%

Lecturer / Post doc 3

4%

Readers' Discipline

Tooltip

Medicine and Dentistry 44

61%

Engineering 18

25%

Pharmacology, Toxicology and Pharmaceut... 5

7%

Biochemistry, Genetics and Molecular Bi... 5

7%

Save time finding and organizing research with Mendeley

Sign up for free
0